2013•European Journal of Clinical PharmacologyRequires access

Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

Dhakchinamoorthi Krishna Kumar, Deepak Gopal Shewade, Marie‐Anne Loriot, Philippe Beaune, Jayaraman Balachander, B.V. Sai Chandran, Adithan Chandrasekaran

Open publisher page 64 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 64 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: VKORC1, Warfarin, CYP2C9, Maintenance dose, Pharmacogenetics, Single-nucleotide polymorphism, Internal medicine, Medicine